Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 03/17/2017
Entire Document
 

AC Immune SA, Ecublens

 

 

6.Total current receivables

 

   As at 31 December,  
in CHF thousands  2016    2015  
       
Other current receivables          
- to third parties   517    269 
- short-term financial receivables   20    20 
Total   537    289 

  

7.Prepaid expenses

 

   As at 31 December,  
in CHF thousands  2016    2015  
       
Prepaid expenses   1,278    339 
Deferred offering costs   -    2,169 
Total   1,278    2,508 

 

8.Share capital

 

As at 31 December 2016, the issued share capital amounted to CHF 1,135,468 is comprised of 56,773,392 common shares at a par value of CHF 0.02 per common share.

 

9.Trade payables and accrued liabilities

 

   As at 31 December,  
in CHF thousands  2016    2015  
       
Trade payables      
- to third parties   2,720    1,295 
- to shareholders   39    - 
           
Accrued payroll expenses   2,560    1,418 
Accrued R&D costs   3,265    1,661 
Other accrued expenses   817    1,682 
Current portion of deferred Income   521    45 
Total accrued expenses and deferred income   7,163    4,806 
Total payables and accrued liabilities   

9,922

    

6,101 

 

 

10.Revenues

 

   As at 31 December,  
in CHF thousands  2016    2015  
       
Collaboration and license revenue   22,737    38,745 
Grant revenue   469    316 
Other   8    39 
Total   23,214    39,100 

 

Statutory Financial Statements9


© AC Immune 2015